Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS.

Nat Microbiol. 2018 Sep;3(9):1075. doi: 10.1038/s41564-018-0155-1.

PMID:
29679064
2.

Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS.

Nat Microbiol. 2018 Feb;3(2):1-8. doi: 10.1038/s41564-017-0080-8. Epub 2018 Jan 1. Erratum in: Nat Microbiol. 2018 Apr 20;:.

PMID:
29292383
3.

The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.

Jiang S, Zhou H, Liang J, Gerdt C, Wang C, Ke L, Schmidt SCS, Narita Y, Ma Y, Wang S, Colson T, Gewurz B, Li G, Kieff E, Zhao B.

Cell Host Microbe. 2017 Oct 11;22(4):561-573.e4. doi: 10.1016/j.chom.2017.09.001.

4.

Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.

Ke L, Zhou H, Wang C, Xiong G, Xiang Y, Ling Y, Khabir A, Tsao GS, Zeng Y, Zeng M, Busson P, Kieff E, Guo X, Zhao B.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9683-9688. doi: 10.1073/pnas.1705236114. Epub 2017 Aug 22.

5.

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.

Ersing I, Nobre L, Wang LW, Soday L, Ma Y, Paulo JA, Narita Y, Ashbaugh CW, Jiang C, Grayson NE, Kieff E, Gygi SP, Weekes MP, Gewurz BE.

Cell Rep. 2017 May 16;19(7):1479-1493. doi: 10.1016/j.celrep.2017.04.062.

6.

Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.

Minamitani T, Ma Y, Zhou H, Kida H, Tsai CY, Obana M, Okuzaki D, Fujio Y, Kumanogoh A, Zhao B, Kikutani H, Kieff E, Gewurz BE, Yasui T.

Proc Natl Acad Sci U S A. 2017 May 2;114(18):4751-4756. doi: 10.1073/pnas.1701836114. Epub 2017 Mar 28.

7.

Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation.

Liang J, Zhou H, Gerdt C, Tan M, Colson T, Kaye KM, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14121-14126. Epub 2016 Nov 18.

8.

Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Hu L, Lin Z, Wu Y, Dong J, Zhao B, Cheng Y, Huang P, Xu L, Xia T, Xiong D, Wang H, Li M, Guo L, Kieff E, Zeng Y, Zhong Q, Zeng M.

Front Med. 2016 Mar;10(1):61-75. doi: 10.1007/s11684-016-0436-0. Epub 2016 Mar 11.

PMID:
26969667
9.

Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.

Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2229-34. doi: 10.1073/pnas.1525444113. Epub 2016 Feb 8.

10.

Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.

Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11612-7. doi: 10.1073/pnas.1514484112. Epub 2015 Aug 24.

11.

Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.

Xiong D, Du Y, Wang HB, Zhao B, Zhang H, Li Y, Hu LJ, Cao JY, Zhong Q, Liu WL, Li MZ, Zhu XF, Tsao SW, Hutt-Fletcher LM, Song E, Zeng YX, Kieff E, Zeng MS.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11036-41. doi: 10.1073/pnas.1513359112. Epub 2015 Aug 19.

12.

Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes.

Verweij FJ, de Heus C, Kroeze S, Cai H, Kieff E, Piersma SR, Jimenez CR, Middeldorp JM, Pegtel DM.

J Extracell Vesicles. 2015 Apr 10;4:26334. doi: 10.3402/jev.v4.26334. eCollection 2015.

13.

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.

Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, Zeng YX, Kieff E, Zeng MS.

Nat Commun. 2015 Feb 11;6:6240. doi: 10.1038/ncomms7240.

14.

Epstein-Barr virus oncoprotein super-enhancers control B cell growth.

Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, Zhao B.

Cell Host Microbe. 2015 Feb 11;17(2):205-16. doi: 10.1016/j.chom.2014.12.013. Epub 2015 Jan 29.

15.

Epstein-Barr virus latent genes.

Kang MS, Kieff E.

Exp Mol Med. 2015 Jan 23;47:e131. doi: 10.1038/emm.2014.84. Review.

16.

Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.

Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):554-9. doi: 10.1073/pnas.1422580112. Epub 2014 Dec 24.

17.

The NF-κB genomic landscape in lymphoblastoid B cells.

Zhao B, Barrera LA, Ersing I, Willox B, Schmidt SC, Greenfeld H, Zhou H, Mollo SB, Shi TT, Takasaki K, Jiang S, Cahir-McFarland E, Kellis M, Bulyk ML, Kieff E, Gewurz BE.

Cell Rep. 2014 Sep 11;8(5):1595-606. doi: 10.1016/j.celrep.2014.07.037. Epub 2014 Aug 21.

18.

The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation.

Hadweh P, Habelhah H, Kieff E, Mosialos G, Hatzivassiliou E.

Cell Signal. 2014 Dec;26(12):2730-7. doi: 10.1016/j.cellsig.2014.08.001. Epub 2014 Aug 16.

PMID:
25134449
19.

Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.

Lee EK, Kim SY, Noh KW, Joo EH, Zhao B, Kieff E, Kang MS.

Antiviral Res. 2014 Apr;104:73-83. doi: 10.1016/j.antiviral.2014.01.018. Epub 2014 Jan 31.

20.

Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.

Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E, Peng CW.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):243-8. doi: 10.1073/pnas.1321800111. Epub 2013 Dec 16.

21.

Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.

Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, Maruo S, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):421-6. doi: 10.1073/pnas.1321704111. Epub 2013 Dec 16.

22.

Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.

Kim JE, Kim SY, Lim SY, Kieff E, Song YJ.

Mol Cell Biol. 2014 Feb;34(3):325-34. doi: 10.1128/MCB.00912-13. Epub 2013 Nov 18.

23.

Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, Kieff E.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18537-42. doi: 10.1073/pnas.1317608110. Epub 2013 Oct 28.

24.

A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation.

Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, Kieff E, Davis BM, Waldor MK.

Cell Rep. 2013 May 30;3(5):1690-702. doi: 10.1016/j.celrep.2013.03.039. Epub 2013 Apr 25.

25.

The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.

Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng CW.

PLoS Pathog. 2012;8(12):e1003084. doi: 10.1371/journal.ppat.1003084. Epub 2012 Dec 13.

26.

Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.

Liu CD, Cheng CP, Fang JS, Chen LC, Zhao B, Kieff E, Peng CW.

Biochem Biophys Res Commun. 2013 Jan 18;430(3):1097-102. doi: 10.1016/j.bbrc.2012.12.032. Epub 2012 Dec 19.

27.

Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation.

Yasui T, Sakakibara-Yada K, Nishimura T, Morita K, Tada S, Mosialos G, Kieff E, Kikutani H.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21022-7. doi: 10.1073/pnas.1218925110. Epub 2012 Dec 5.

28.

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabási AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Münger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M.

Nature. 2012 Jul 26;487(7408):491-5. doi: 10.1038/nature11288.

29.

Viral perturbations of host networks reflect disease etiology.

Gulbahce N, Yan H, Dricot A, Padi M, Byrdsong D, Franchi R, Lee DS, Rozenblatt-Rosen O, Mar JC, Calderwood MA, Baldwin A, Zhao B, Santhanam B, Braun P, Simonis N, Huh KW, Hellner K, Grace M, Chen A, Rubio R, Marto JA, Christakis NA, Kieff E, Roth FP, Roecklein-Canfield J, Decaprio JA, Cusick ME, Quackenbush J, Hill DE, Münger K, Vidal M, Barabási AL.

PLoS Comput Biol. 2012;8(6):e1002531. doi: 10.1371/journal.pcbi.1002531. Epub 2012 Jun 28.

30.

Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization.

Kim SY, Song KA, Kieff E, Kang MS.

Biochem Biophys Res Commun. 2012 Jul 27;424(2):251-6. doi: 10.1016/j.bbrc.2012.06.095. Epub 2012 Jun 23.

PMID:
22735264
31.

Genome-wide siRNA screen for mediators of NF-κB activation.

Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2467-72. doi: 10.1073/pnas.1120542109. Epub 2012 Jan 17.

32.

Latent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.

Geiser V, Cahir-McFarland E, Kieff E.

PLoS One. 2011;6(8):e22929. doi: 10.1371/journal.pone.0022929. Epub 2011 Aug 11.

33.

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.

Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14902-7. doi: 10.1073/pnas.1108892108. Epub 2011 Jul 11.

34.

Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J, Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14908-13. doi: 10.1073/pnas.1109023108. Epub 2011 Jul 7.

35.

cis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression.

Xing L, Kieff E.

J Virol. 2011 Sep;85(17):8929-39. doi: 10.1128/JVI.00336-11. Epub 2011 Jun 22.

36.

Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.

Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E.

J Virol. 2011 Jul;85(13):6764-73. doi: 10.1128/JVI.00422-11. Epub 2011 May 4.

37.

LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.

Verweij FJ, van Eijndhoven MA, Hopmans ES, Vendrig T, Wurdinger T, Cahir-McFarland E, Kieff E, Geerts D, van der Kant R, Neefjes J, Middeldorp JM, Pegtel DM.

EMBO J. 2011 Jun 1;30(11):2115-29. doi: 10.1038/emboj.2011.123. Epub 2011 Apr 28.

38.

EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7808-13. doi: 10.1073/pnas.1104991108. Epub 2011 Apr 25.

39.

Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.

Calderwood MA, Lee S, Holthaus AM, Blacklow SC, Kieff E, Johannsen E.

Virology. 2011 May 25;414(1):19-25. doi: 10.1016/j.virol.2011.02.018. Epub 2011 Mar 26.

40.

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.

Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1919-24. doi: 10.1073/pnas.1019599108. Epub 2011 Jan 18.

41.

Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance.

Kang MS, Lee EK, Soni V, Lewis TA, Koehler AN, Srinivasan V, Kieff E.

J Virol. 2011 Mar;85(6):2859-68. doi: 10.1128/JVI.01628-10. Epub 2011 Jan 5.

42.

Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, Holton K, Rubio R, Takada K, Quackenbush J, Kieff E.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):337-42. doi: 10.1073/pnas.1017419108. Epub 2010 Dec 20.

43.

Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Boehm D, Gewurz BE, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18103-8. doi: 10.1073/pnas.1011752107. Epub 2010 Oct 5.

44.

Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Lee S, Sakakibara S, Maruo S, Zhao B, Calderwood MA, Holthaus AM, Lai CY, Takada K, Kieff E, Johannsen E.

J Virol. 2009 Dec;83(23):12368-77. doi: 10.1128/JVI.01403-09. Epub 2009 Sep 23.

45.

Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

Maruo S, Wu Y, Ito T, Kanda T, Kieff ED, Takada K.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4419-24. doi: 10.1073/pnas.0813134106. Epub 2009 Feb 23.

46.

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.

Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M.

Genome Res. 2009 Mar;19(3):438-51. doi: 10.1101/gr.083550.108. Epub 2009 Feb 10.

47.

Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines.

Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, De Jager PL, Shaw SY, Wolfish CS, Slavik JM, Cotsapas C, Rivas M, Dermitzakis ET, Cahir-McFarland E, Kieff E, Hafler D, Daly MJ, Altshuler D.

PLoS Genet. 2008 Nov;4(11):e1000287. doi: 10.1371/journal.pgen.1000287. Epub 2008 Nov 28.

48.

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.

49.

Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice.

Kang MS, Soni V, Bronson R, Kieff E.

J Virol. 2008 Apr;82(8):4180-3. doi: 10.1128/JVI.02596-07. Epub 2008 Feb 6.

50.

LMP1 TRAFficking activates growth and survival pathways.

Soni V, Cahir-McFarland E, Kieff E.

Adv Exp Med Biol. 2007;597:173-87. Review.

PMID:
17633026

Supplemental Content

Support Center